Brisbane, Australia | National Telehealth Service
reception@genderhealth.com.au

Return of Spermatogenesis in Trans Women

September 12, 2025

Return of Spermatogenesis in Trans Women

🧠 Geek Out: When Sperm Returns — Reversible Spermatogenesis in Trans Women

📚 Study Overview:
Yau & Safer (2023) review a study by de Nie et al., published in Cell Reports Medicine, showing that anti-androgen and estrogen therapy (GAHT) doesn’t always mean permanent infertility for trans women.

What’s the Big Deal?

Many people assume that estrogen + anti-androgen therapy permanently stops sperm production. But this study followed nine transgender women who stopped GAHT because they wanted to conceive or preserve fertility—and all of them regained sperm production!

Key Findings

  • Viable sperm appeared in all 9 individuals after they stopped GAHT.
  • Time to return varied — some as early as a few months, others took over a year.
  • There was no obvious link between how long someone had been on GAHT and how quickly sperm returned.

Why It Matters

  • Infertility isn’t set in stone. GAHT-related suppression of sperm production may be reversible, giving hope for future fertility.
  • This challenges common advice that GAHT inevitably means permanent sterility.
  • It can change how clinicians counsel trans women considering GAHT—especially if they’re unsure about future parenthood.

Study Limitations

  • Very small sample size (just nine people), so findings are preliminary.
  • More research needed to confirm results across larger and more diverse groups.